Literature DB >> 15070171

Effects of Keishi-bukuryo-gan on vascular function and hemorheological factors in spontaneously diabetic (WBN/kob) rats.

H Goto1, Y Shimada, N Sekiya, Q Yang, T Kogure, N Mantani, H Hikiami, N Shibahara, K Terasawa.   

Abstract

Keishi-bukuryo-gan (Gui-zhi-fu-ling-wan) is a formula used for the improvement of blood circulation. Recently it has often also been used for arteriosclerosis. One of the mechanisms involved is thought to be the improvement of endothelial dysfunction, but the details are still unclear. In this study, the effect of Keishi-bukuryo-gan on vascular function and hemorheological factors in spontaneously diabetic (WBN/kob) rats was studied. Rats were given Keishi-bukuryo-gan in chow for 30 weeks. Body weight, blood glucose, endothelium-dependent/-independent relaxation, vasocontraction by free radical-induced and contractive prostanoids, triglyceride, advanced glycation endproduct, lipid peroxides, serum NO2-/NO3- and blood viscosity were measured. The results indicated that Keishi-bukuryo-gan caused a decrease in endothelium-dependent relaxation by acetylcholine to become significantly increased, and vasocontraction induced by free radicals and contractive prostanoids was significantly decreased. Furthermore, serum NO2-/NO3- and blood viscosity were significantly decreased. From these results, it was supposed that Keishi-bukuryo-gan exerted a protective effect on the endothelium. The WBN/kob rat is a useful study model for the complications of human diabetes, and Keishi-bukuryo-gan showed a protective effect against vascular injury in the susceptible rat.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15070171     DOI: 10.1078/0944-7113-00336

Source DB:  PubMed          Journal:  Phytomedicine        ISSN: 0944-7113            Impact factor:   5.340


  13 in total

Review 1.  What has been overlooked on study of Chinese materia medica in the West?

Authors:  Willow J H Liu
Journal:  Chin J Integr Med       Date:  2015-07-09       Impact factor: 1.978

2.  Examination of clinical efficacy of keishibukuryogan on non-specific complaints associated with varicose veins of the lower extremity.

Authors:  Shinobu Hayashi; Shintaro Shibutani; Hirotoki Okubo; Tatsuya Shimogawara; Tsuyoshi Ichinose; Yasuhiro Ito; Kouki Mihara; Tomohisa Egawa; Atsushi Nagashima; Hideaki Obara; Yuko Kitagawa
Journal:  Ann Vasc Dis       Date:  2014-07-30

3.  Relationship between Blood Stasis Syndrome Score and Cardioankle Vascular Index in Stroke Patients.

Authors:  Ki-Ho Cho; Kyoo-Pil Kim; Byung-Cheol Woo; Young-Jee Kim; Joo-Young Park; Seung-Yeon Cho; Seong-Uk Park; Woo-Sang Jung; Jung-Mi Park; Sang-Kwan Moon
Journal:  Evid Based Complement Alternat Med       Date:  2012-05-31       Impact factor: 2.629

4.  Effect of keishibukuryogan on endothelial function in patients with at least one component of the diagnostic criteria for metabolic syndrome: a controlled clinical trial with crossover design.

Authors:  Yutaka Nagata; Hirozo Goto; Hiroaki Hikiami; Tatsuya Nogami; Makoto Fujimoto; Naotoshi Shibahara; Yutaka Shimada
Journal:  Evid Based Complement Alternat Med       Date:  2012-05-22       Impact factor: 2.629

5.  The traditional Japanese formula keishibukuryogan inhibits the production of inflammatory cytokines by dermal endothelial cells.

Authors:  Yoko Yoshihisa; Megumi Furuichi; Mati Ur Rehman; Chieko Ueda; Teruhiko Makino; Tadamichi Shimizu
Journal:  Mediators Inflamm       Date:  2010-12-28       Impact factor: 4.711

6.  Keishibukuryogan (gui-zhi-fu-ling-wan), a Kampo formula, decreases disease activity and soluble vascular adhesion molecule-1 in patients with rheumatoid arthritis.

Authors:  Kazuya Nozaki; Hiroaki Hikiami; Hirozo Goto; Takako Nakagawa; Naotoshi Shibahara; Yutaka Shimada
Journal:  Evid Based Complement Alternat Med       Date:  2006-09       Impact factor: 2.629

7.  Effect of keishibukuryogan on genetic and dietary obesity models.

Authors:  Fengying Gao; Satoru Yokoyama; Makoto Fujimoto; Koichi Tsuneyama; Ikuo Saiki; Yutaka Shimada; Yoshihiro Hayakawa
Journal:  Evid Based Complement Alternat Med       Date:  2015-02-22       Impact factor: 2.629

8.  Keishibukuryogan, a Traditional Japanese Medicine, Inhibits Platelet Aggregation in Guinea Pig Whole Blood.

Authors:  Kiyoshi Terawaki; Masamichi Noguchi; Mitsutoshi Yuzurihara; Yuji Omiya; Yasushi Ikarashi; Yoshio Kase
Journal:  Evid Based Complement Alternat Med       Date:  2015-08-24       Impact factor: 2.629

9.  Guizhi-Fuling-Wan, a Traditional Chinese Herbal Medicine, Ameliorates Memory Deficits and Neuronal Apoptosis in the Streptozotocin-Induced Hyperglycemic Rodents via the Decrease of Bax/Bcl2 Ratio and Caspase-3 Expression.

Authors:  Kuo-Jen Wu; Yuh-Fung Chen; Huei-Yann Tsai; Chi-Rei Wu; W Gibson Wood
Journal:  Evid Based Complement Alternat Med       Date:  2012-10-31       Impact factor: 2.629

10.  Keishibukuryogan reduces renal injury in the early stage of renal failure in the remnant kidney model.

Authors:  Takako Nakagawa; Izumi Tashiro; Makoto Fujimoto; Michiko Jo; Shinya Sakai; Hiroshi Oka; Hirozo Goto; Yutaka Shimada; Naotoshi Shibahara
Journal:  Evid Based Complement Alternat Med       Date:  2011-05-03       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.